Cancer Letters
Volume 223, Issue 2 , Pages 265-274 , 8 June 2005

Rapid detection of single nucleotide polymorphisms related with lung cancer susceptibility of Chinese population

Received 16 November 2004 ,Revised 27 December 2004 ,Accepted 29 December 2004.

References 

  1. Wu XY, Zhang XD, Gu ZL, Zhou GH. Detection of human gene ABC1 mutant point I823M by di-allele specific amplification with artificially modified primers. Chin. J. Med. Genet. 2004;21:86–88
  2. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, et al. Activation of chemically diverse procarcinogens by human cytochrome P4501B1. Cancer Res. 1996;56:2979–2984
  3. Murray GI, Taylor MC, McFadyen MC, McKay JA, Greenlee WF, Burke MD, et al. Tumor specific expression of cytochrome P450 CYP1B1. Cancer Res. 1997;57:3026–3031
  4. Ko Y, Abel J, Harth V, Brode P, Antony C, Donat S, et al. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Res. 2001;61:4398–4404
  5. Zheng W, Xie DW, Jin F, Cheng JR, Dai Q, Wen WQ, et al. Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 2000;9:147–150
  6. Sasaki M, Tanaka Y, Okino ST, Nomoto M, Yonezawa S, Nakagawa M, et al. Polymorphisms of the CYP1B1 gene as risk factors for human renal cell cancer. Clin. Cancer Res. 2004;10:2015–2019
  7. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R. CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor α and estrogen receptor β expressions. Cancer Res. 2003;63:3913–3918
  8. Tang YM, Green BL, Chen GF, Thompson PA, Lang NP, Shinde A, et al. Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controls. Pharmacogenetics. 2000;10:761–766
  9. Watson MA, Stewart RK, Smith GBJ, Massey TE, Bell DA. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis. 1998;19:275–280
  10. Hu X, Herzog C, Zimniak P, Singh SV. Differential protection against benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxideinduced DNA damage in HepG2 cells stably transfected with allelic variants of pi class human glutathione S-transferase. Cancer Res. 1999;59:2358–2362
  11. Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 1997;18:1285–1289
  12. Stucker I, Hirvonen A, de Waziers I, Cabelguenne A, Mitrunen K, Cenee S, et al. Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. Carcinogenesis. 2002;23:1475–1481
  13. Lin PP, Hsueh YM, Ko JL, Liang YF, Tsai K, Chen CY. Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan. Lung Cancer. 2003;40:123–129
  14. Sugimura H, Kohno T, Wakai K, Nagura K, Genka K, Igarashi H, et al. HOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 1999;8:669–674
  15. Park J, Chen L, Tockman MS, Elahi A, Lazarus P. The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics. 2004;14:103–109
  16. Davidson S. Research suggests importance of haplotypes over SNPs. Nat. Biotechnol. 2000;18:1134–1135
  17. Ye S, Humphries S, Green F. Allele specific amplification by tetra-primer PCR. Nucleic Acids Res. 1992;20:1152
  18. Nie LH, Wang SY, Hu YL. Genetic polymorphism of glutathione S-transferase P1 gene and susceptibility to lung cancer. China Public Health. 2002;18:791–792
  19. Gao CM, Sugimura H, Takezaki T, Wu JZ, Li ZY, Ding JH, et al. HOGG1 genotypes, life style and the risk of esophageal and stomach cancers. China Tumor. 2001;10:500–502
  20. Hecht SS. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 1999;91:1194–1210
  21. Watanabe J, Shimada T, Gillam EM, Ikuta T, Suemasu K, Higashi Y, et al. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics. 2000;10:25–33
  22. Anttila S, Hirvonen A, Vainio H, Husgafvel-Pursiainen K, Hayes JD, Ketterer B. Immunohistochemical localization of glutathione S-transferases in human lung. Cancer Res. 1993;53:5643–5648
  23. Zimniak P, Nanduri B, Pikula S, Bandorowicz-Pikula J, Singhal SS, Srivastava SK, et al. Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties. Eur. J. Biochem. 1994;224:893–899
  24. Schneider J, Bernges U, Philipp M, Woitowitz HJ. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. Cancer Lett. 2004;208:65–74
  25. Lewis SJ, Cherry NM, Niven RM, Barber PV, Povey AC. GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Lett. 2002;180:165–171
  26. Wang JW, Deng YF, Cheng JL, Ding JM, Tokudome SK. GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Lett. 2003;201:185–193
  27. Kohno T, Shinmura K, Tosaka M, Tani M, Kim SR, Sugimura H, et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene. 1998;16:3219–3225
  28. Marchand LL, Donlon T, Lum-Jones A, Seifried A, Wilkens LR. Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 2002;11:409–412
  29. Ito H, Hamajima N, Takezaki T, Matsuo K, Tajima K, Hatooka S, et al. A limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung. J. Epidemiol. 2002;12:258–265

PII: S0304-3835(05)00026-1

doi: 10.1016/j.canlet.2004.12.042

Cancer Letters
Volume 223, Issue 2 , Pages 265-274 , 8 June 2005

Article Tools

* Image Usage & Resolution